Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Inventory (2016 - 2025)

Vanda Pharmaceuticals (VNDA) has disclosed Change in Inventory for 13 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 1096.26% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Dec 2025, up 11851.72% year-over-year, with the annual reading at $3.5 million for FY2025, 11851.72% up from the prior year.
  • Change in Inventory hit $1.3 million in Q4 2025 for Vanda Pharmaceuticals, up from -$32000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.8 million in Q1 2025 to a low of -$263000.0 in Q2 2024.
  • Historically, Change in Inventory has averaged $548900.0 across 5 years, with a median of $385500.0 in 2022.
  • Biggest five-year swings in Change in Inventory: crashed 133.75% in 2023 and later skyrocketed 6479.31% in 2025.
  • Year by year, Change in Inventory stood at $77000.0 in 2021, then soared by 1367.53% to $1.1 million in 2022, then plummeted by 62.21% to $427000.0 in 2023, then tumbled by 74.94% to $107000.0 in 2024, then skyrocketed by 1096.26% to $1.3 million in 2025.
  • Business Quant data shows Change in Inventory for VNDA at $1.3 million in Q4 2025, -$32000.0 in Q3 2025, and $368000.0 in Q2 2025.